Galectin Therap
GALT----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Galectin Therap(GALT) predict that the EBIT is -4.077 M (+48.37%), Miss estimate;the EPS is -0.08 (+46.67%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.00B48.37%
-0.00B50.61%
-0.00B2.24%
EPSMiss expectations
-0.0846.67%
-0.0660.00%
-0.020013.33%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf